🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascen...
Status
Completed
Location
PPD 137
Start Date
2015-06-12
Trial ID
NCT02462187
Treatments Being Tested
Phase 2 study designed to evaluated analgesic efficacy and safety of S-Ibup...
Status
Completed
Location
JBR Clinical Research
Start Date
2018-01-12
Trial ID
NCT03852459
Treatments Being Tested
To explore the pharmacodynamics and evaluate safety, tolerability and clini...
Status
Unknown
Location
Centre for Human Drug Research
Start Date
2018-10-22
Trial ID
NCT03684772
Treatments Being Tested
Painful diabetic neuropathy is the most common cause of neuropathic pain. 0...
Status
Completed
Location
Thammasat University Hospital
Start Date
2009-10
Trial ID
NCT00993070
The purpose of this study is find out whether Oleogel-S10 is an effective t...
Status
Completed
Location
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities)
Start Date
2021-12-15
Trial ID
NCT05190770
Treatments Being Tested
This study is to evaluate the therapeutic equivalence and safety of Taro Pr...
Status
Completed
Location
Catawba Research, LLC
Start Date
2019-03-20
Trial ID
NCT04134273
Treatments Being Tested
Periodontal disease (commonly called gum disease) is generally treated by d...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00529555
Treatments Being Tested
This study is designed to evaluate the analgesic safety and efficacy of stu...
Status
Completed
Location
Lotus Clinical Research, LLC
Start Date
2015-01
Trial ID
NCT02324985
Treatments Being Tested
This is a Phase 3 efficacy and safety study of CD07805/47 topical gel in su...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2011-05
Trial ID
NCT01355471
Treatments Being Tested
Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl...
Status
Completed
Location
Alliance Dermatology
Start Date
2015-05
Trial ID
NCT02616614
Treatments Being Tested